Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of COVID-19 cases in the early phase (March to July 2020) of the pandemic in Kenya.
Ngere P, Onsongo J, Langat D, Nzioka E, Mudachi F, Kadivane S, Chege B, Kirui E, Were I, Mutiso S, Kibisu A, Ihahi J, Mutethya G, Mochache T, Lokamar P, Boru W, Makayotto L, Okunga E, Ganda N, Haji A, Gathenji C, Kariuki W, Osoro E, Kasera K, Kuria F, Aman R, Nabyonga J, Amoth P. Ngere P, et al. Among authors: kirui e. J Glob Health. 2022 Dec 30;12:15001. doi: 10.7189/jogh.12.15001. J Glob Health. 2022. PMID: 36583253 Free PMC article. Review.
Estimating the economic impact of COVID-19 disruption on access to sexual and reproductive health and rights in Eastern and Southern Africa.
Kipchumba Kipruto H, Cyprian Karamagi H, Ngusbrhan Kidane S, Mwai D, Njuguna D, Droti B, Muthigani W, Olwanda E, Kirui E, Adegboyega AA, Onyiah AP, Nabyonga-Orem J. Kipchumba Kipruto H, et al. Among authors: kirui e. Front Public Health. 2023 Jun 22;11:1144150. doi: 10.3389/fpubh.2023.1144150. eCollection 2023. Front Public Health. 2023. PMID: 37427280 Free PMC article.
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
Khaemba C, Barry A, Omondi WP, Kirui E, Oluka M, Parthasarathi G, Njenga SM, Guantai A, Aklillu E. Khaemba C, et al. Among authors: kirui e. Drug Saf. 2023 Oct;46(10):961-974. doi: 10.1007/s40264-023-01338-9. Epub 2023 Aug 8. Drug Saf. 2023. PMID: 37552438 Free PMC article.
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.
Khaemba C, Barry A, Omondi WP, Bota K, Matendechero S, Wandera C, Siyoi F, Kirui E, Oluka M, Nambwa P, Gurumurthy P, Njenga SM, Guantai A, Aklillu E. Khaemba C, et al. Among authors: kirui e. Pharmaceuticals (Basel). 2021 Mar 15;14(3):264. doi: 10.3390/ph14030264. Pharmaceuticals (Basel). 2021. PMID: 33804133 Free PMC article.